Log in to save to my catalogue

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasio...

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasio...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2706689168

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis

About this item

Full title

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis

Publisher

San Francisco: Public Library of Science

Journal title

PloS one, 2022-08, Vol.17 (8), p.e0273242-e0273242

Language

English

Formats

Publication information

Publisher

San Francisco: Public Library of Science

More information

Scope and Contents

Contents

Reduced expression in immortalized cells/Dickkopf-3 (REIC/Dkk-3) is a tumor suppressor and its overexpression has been shown to exert anti-tumor effects as a therapeutic target gene in many human cancers. Recently, we demonstrated the anti-glioma effects of an adenoviral vector carrying REIC/Dkk-3 with the super gene expression system (Ad-SGE-REIC)...

Alternative Titles

Full title

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2706689168

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2706689168

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0273242

How to access this item